SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 55.32+2.7%Jan 12 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who started this subject3/4/2004 11:49:12 AM
From: scaram(o)uche  Read Replies (4) of 52153
 
The question to sell? Position traders sell when they can. My example of having purchased SEPR at the very bottom, lamenting that I sold at $6?

I put away more profit, in absolute terms, than many who held until now ($46). For many years, we've shown in the T/FIF thread that a degree of safety can ALWAYS be found in biotech, as capitalizations vary widely from fundamental value.

There is no rule. Biotech's volatility means that there's always another bus, first, and position trades were by far the most productive 2000-2003. Moreover, the CLASSIC biotech investor doesn't need to sell, as his or her positions are largely aimed at munch. Neither he nor she will touch these lousy companies that sell stuff.

:-)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News